Holdings
Eversept Partners, LP
As of Sep 30, 2026, Eversept Partners, LP reported 102 positions worth US$1.72B. Largest: United Therapeutics Corporation, Encompass Health Corporation and The Ensign Group, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| United Therapeutics Corporation | 325K | US$176M | +37,061 | Sep 30, 2026 |
| Encompass Health Corporation | 1.08M | US$131M | +55,397 | Sep 30, 2026 |
| The Ensign Group, Inc. | 726K | US$125M | +124K | Sep 30, 2026 |
| Abivax SA | 1.1M | US$109M | +187K | Sep 30, 2026 |
| Vera Therapeutics, Inc. | 2.36M | US$76.3M | +149K | Sep 30, 2026 |
| Revvity, Inc. | 450K | US$68.8M | +366K | Sep 30, 2026 |
| Natera, Inc. | 128K | US$53M | −47,681 | Sep 30, 2026 |
| CareTrust REIT, Inc. | 1.35M | US$49.5M | +281K | Sep 30, 2026 |
| Omega Healthcare Investors, Inc. | 1.01M | US$46.7M | +525K | Sep 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 2.44M | US$45.9M | −355K | Sep 30, 2026 |